Join Clinical Trials
  • Login
  • Home
  • Clinical Trial Categories
  • Clinical Trials by Condition
  • Cc
  • Cardiomyopathy, Hypertrophic


Menu

Choose Which Database to Search - Volunteer Database - Clinical Trial Database Create an Account - VOLUNTEER Accounts - RECRUITER Accounts Account Login - Volunteers Login - Recruiters Login Join a Clinical Trial Clinical Trials by Category Clinical Trials by Location Submit a Clinical Trial Frequently Asked Questions Contact Us Sitemap Blog

Categories

    Healthy Volunteers Adults - 18 - 64 Youths - Birth - 17 Seniors - 65 + Expanded Access Compensated Trials Clinical Trials by Condition Trials by Drug Type Trials for Rare Conditions

Recent Listings

  • Post your clinical trial on JoinClinicalTrials.com

    Ellijay, Georgia 30536
    United States

    Post your clinical trial on JoinClinicalTrials.com

    05-09-2019 01:01PM

JoinClinicalTrials.com





  • Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
    NCT03846297
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting
  • French Hypertrophic Cardiomyopathy Observatory
    NCT01091480
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsor:   French Cardiology Society
    Recruiting
  • Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy?
    NCT03537183
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:   Other: Exercise training
    Sponsors:   Bispebjerg Hospital;   Rigshospitalet, Denmark
    Recruiting
  • A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
    NCT04112290
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsor:   Mayo Clinic
    Recruiting
  • 3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
    NCT03550573
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:   Device: CardioInsight™ Noninvasive 3D Mapping System
    Sponsor:   Hospices Civils de Lyon
    Not yet recruiting
  • Study of Myocardial Deformation Parameters in Patients With Hypertrophic Cardiomyopathy
    NCT04112511
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsor:   AHEPA University Hospital
    Recruiting
  • Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
    NCT04133532
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:   Drug: Metoprolol
    Sponsor:   University Hospital, Motol
    Not yet recruiting
  • Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy
    NCT03726424
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsor:   Tongji Hospital
    Recruiting
  • Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
    NCT03327623
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsors:   Mayo Clinic;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting
  • Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy
    NCT03832660
    Condition:   Hypertrophic Cardiomyopathy
    Interventions:   Behavioral: Lifestyle;   Drug: Sacubitril/Valsartan
    Sponsors:   Newcastle University;   Azienda Ospedaliero-Universitaria Careggi;   University Hospital Regensburg;   Institute for Cardiovascular Diseases of Vojvodina;   University of Belgrade
    Recruiting
  • Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy
    NCT04157205
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:   Diagnostic Test: Non-invasive ECG imaging - CardioInsight test
    Sponsors:   Imperial College London;   Imperial College Healthcare NHS Trust;   Medtronic;   Barts & The London NHS Trust;   University of Oxford;   Daniel Bagshaw Trust
    Recruiting
  • High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy
    NCT03335332
    Condition:   Hypertrophic Cardiomyopathy
    Interventions:   Behavioral: High intensity exercise;   Behavioral: Moderate intensity exercise
    Sponsors:   University of Texas Southwestern Medical Center;   Biotronik SE & Co. KG
    Recruiting
  • Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
    NCT02922517
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsors:   Nantes University Hospital;   University Hospital, Lille;   Rennes University Hospital;   Institut National de la Santé Et de la Recherche Médicale, France
    Recruiting
  • Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy
    NCT02994615
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsor:   Lawson Health Research Institute
    Recruiting
  • Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease
    NCT03271385
    Conditions:   Hypertrophic Cardiomyopathy;   Hypertensive Heart Disease
    Intervention:   Diagnostic Test: evaluated by the predetermined differentiating formula
    Sponsors:   RenJi Hospital;   Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University;   Ruijin Hospital;   LanZhou University;   Kunming Medical University;   Beijing Anzhen Hospital;   West China Hospital
    Recruiting
  • Assessment of the Relations Between Endothelial and Venous Dysfunctions and Left Ventricular Obstruction in Genetic Hypertrophic Cardiomyopathies
    NCT04129905
    Conditions:   Hypertrophic Cardiomyopathy;   Endothelial Dysfunction
    Interventions:   Biological: BNP blood sample test;   Diagnostic Test: Electrocardiogram;   Diagnostic Test: Holter ECG;   Diagnostic Test: Echocardiography;   Diagnostic Test: Air venous plethysmography;   Diagnostic Test: Upper member arterial Doppler echography with analysis of FMD;   Biological: Endothelial function biomarkers
    Sponsors:   University Hospital, Bordeaux;   Fédération Française de Cardiologie;   Fondation Bordeaux Université;   Amicus Therapeutics
    Not yet recruiting
  • Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy
    NCT02948998
    Conditions:   Hypertrophic Cardiomyopathy;   Fibrosis
    Intervention:   Drug: Spironolactone
    Sponsors:   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;   Ruijin Hospital;   RenJi Hospital;   Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
    Not yet recruiting
  • Non-Invasive Radiation Ablation in Patients With Hypertrophic CardioMyopathy: NIRA-HOCM
    NCT04153162
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:   Device: Stereotactic body radiation therapy
    Sponsors:   Barts & The London NHS Trust;   Barts Cardiovascular CTU (Queen Mary University of London);   Barts Charity
    Not yet recruiting
  • CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM
    NCT01332162
    Condition:   Hypertrophic Obstructive Cardiomyopathy (HOCM)
    Interventions:   Device: Biventricular pacing;   Device: No Pacing
    Sponsor:   Hospital Clinic of Barcelona
    Recruiting
  • Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM
    NCT03092843
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsor:   The Cleveland Clinic
    Recruiting
  • Efficacy of Psychotherapy for Improving Quality of Life in Patients With Hypertrophic Cardiomyopathy and Depression
    NCT03706001
    Conditions:   Hypertrophic Cardiomyopathy;   Depression;   Anxiety;   Psychotherapy
    Intervention:   Other: Psychotherapy
    Sponsor:   Xijing Hospital
    Not yet recruiting
  • Mitral Valve in Hypertrophic Cardiomyopathy
    NCT03877731
    Condition:   Hypertrophic Obstructive Cardiomyopathy
    Interventions:   Procedure: isolated septal myectomy;   Procedure: septal myectomy + edge-to-edge mitral valve repair;   Procedure: septal myectomy + posterior leaflet sliding plasty;   Procedure: septal myectomy + secondary chordae transection
    Sponsor:   Tomsk National Research Medical Center of the Russian Academy of Sciences
    Recruiting
  • HCM-AF Ablation With ACUTUS
    NCT04090437
    Conditions:   Atrial Fibrillation;   Hypertrophic Cardiomyopathy
    Intervention:   Procedure: Catheter ablation procedure
    Sponsors:   Royal Brompton & Harefield NHS Foundation Trust;   Acutus Medical
    Not yet recruiting
  • The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
    NCT02696135
    Condition:   Cardiomyopathy, Hypertrophic
    Intervention:  
    Sponsor:   China National Center for Cardiovascular Diseases
    Recruiting
  • Study of Efficacy of Oral Sacubitril/Valsartan Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
    NCT04164732
    Condition:   Cardiomyopathy, Hypertrophic
    Interventions:   Drug: LCZ696;   Drug: Placebo
    Sponsor:   Novartis Pharmaceuticals
    Not yet recruiting
  • The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.
    NCT03532802
    Condition:   Hypertrophic Cardiomyopathy
    Interventions:   Drug: Metoprolol Succinate;   Drug: Placebo oral capsule
    Sponsor:   Steen Hvitfeldt Poulsen
    Recruiting
  • OPIE in the Thin Interventricular Septum
    NCT04050579
    Condition:   Hypertrophic Cardiomyopathy
    Intervention:   Device: on-pump intracardiac echocardiography
    Sponsor:   NYU Langone Health
    Not yet recruiting
  • Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy
    NCT03043209
    Conditions:   Hypertrophic Cardiomyopathy;   Genetic Disease;   Gene Product Sequence Variation
    Intervention:   Genetic: Genomic sequencing
    Sponsor:   The Cleveland Clinic
    Recruiting
  • Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy
    NCT03953989
    Condition:   HCM - Hypertrophic Non-Obstructive Cardiomyopathy
    Intervention:   Drug: Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die
    Sponsors:   IRCCS San Raffaele;   Menarini International Operations Luxembourg SA
    Recruiting
  • Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy
    NCT03450252
    Condition:   Cardiomyopathy, Hypertrophic
    Interventions:   Device: Active pacing;   Device: Back-up pacing
    Sponsor:   Barts & The London NHS Trust
    Recruiting
  • "Cardiac Rehabilitation in Patients With Hypertrophic Cardiomyopathy".
    NCT03178357
    Condition:   Cardiac Rehabilitation
    Interventions:   Other: Cardiac rehabilitation + standard therapy;   Other: Standard therapy
    Sponsor:   Institute of Cardiology, Warsaw, Poland
    Recruiting
  • Extended ECG Monitoring in HCM Patients
    NCT04056715
    Conditions:   Hypertrophic Cardiomyopathy;   Nonsustained Ventricular Tachycardia;   Ventricular Tachycardia;   Atrial Fibrillation;   Arrhythmia
    Intervention:   Device: Zio XT
    Sponsor:   iRhythm Technologies, Inc.
    Not yet recruiting
  • Biomarkers in Aortic Stenosis - B.A.S.S.
    NCT01334801
    Conditions:   Aortic Stenosis;   Disorder of Prosthetic Cardiac Valve;   Aortic Valve Insufficiency;   Mitral Valve Insufficiency;   Hypertrophic Cardiomyopathy;   Tricuspid Valve Insufficiency
    Intervention:   Procedure: Blood Draw
    Sponsor:   Mayo Clinic
    Recruiting
  • Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve
    NCT03249272
    Conditions:   Hypertrophic Cardiomyopathy;   Non-ischemic Dilated Cardiomyopathy;   Microvascular Ischaemia of Myocardium
    Interventions:   Drug: Regadenoson;   Drug: Adenosine
    Sponsor:   Duke University
    Recruiting
  • The Effect of TASH in Patients With HOCM
    NCT04066777
    Condition:   Hypertrophic Obstructive Cardiomyopathy
    Intervention:   Procedure: alcohol septal ablation
    Sponsor:   Steen Hvitfeldt Poulsen
    Recruiting
  • Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium
    NCT03607669
    Conditions:   Ischemic Cardiomyopathy;   Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy
    Intervention:   Other: Mangafodipir trisodium
    Sponsor:   University of Edinburgh
    Recruiting
  • Molecular and Imaging Studies of Cardiovascular Health and Disease
    NCT02804269
    Conditions:   Healthy;   Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy;   Ischemic Heart Disease
    Interventions:   Other: Cardiovascular Magnetic Resonance;   Other: Fatmass measurement
    Sponsor:   National Heart Centre Singapore
    Recruiting
  • Evaluation of HEArt invoLvement in Patients With FABRY Disease
    NCT03362164
    Conditions:   Rare Diseases;   Fabry Disease;   Fabry Disease, Cardiac Variant;   Hypertrophic Cardiomyopathy
    Intervention:  
    Sponsors:   Wuerzburg University Hospital;   Competence Network Heart Failure;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   St George's, University of London
    Recruiting
  • Metabolomic Study of All-age Cardiomyopathy
    NCT03061994
    Conditions:   Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy;   Arrhythmogenic Right Ventricular Cardiomyopathy;   Left Ventricular Non-compaction;   Restrictive Cardiomyopathy
    Intervention:  
    Sponsor:   Beijing Institute of Heart, Lung and Blood Vessel Diseases
    Recruiting
  • An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
    NCT03076580
    Conditions:   Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy;   Arrhythmogenic Right Ventricular Cardiomyopathy;   Left Ventricular Non-compaction;   Restrictive Cardiomyopathy
    Intervention:  
    Sponsors:   Beijing Institute of Heart, Lung and Blood Vessel Diseases;   Chinese Academy of Medical Sciences, Fuwai Hospital;   Beijing Anzhen Hospital
    Recruiting
  • Gene Therapy for Male Patients With Danon Disease Using RP-A501; AAV9.LAMP2B
    NCT03882437
    Condition:   Danon Disease
    Intervention:   Biological: RP-A501
    Sponsor:   Rocket Pharmaceuticals Inc.
    Recruiting
  • Pediatric Cardiomyopathy Mutation Analysis
    NCT02432092
    Conditions:   Cardiomyopathies;   Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy;   Restrictive Cardiomyopathy;   Arrhythmogenic Right Ventricular Cardiomyopathy;   Left Ventricular Non-compaction Cardiomyopathy
    Intervention:  
    Sponsors:   Indiana University;   American Heart Association
    Recruiting
  • Risk Stratification in Children and Adolescents With Primary Cardiomyopathy
    NCT03572569
    Conditions:   Primary Cardiomyopathy;   Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy;   Left Ventricular Noncompaction;   Restrictive Cardiomyopathy;   Arrhythmogenic Right Ventricular Cardiomyopathy
    Intervention:  
    Sponsors:   German Heart Institute;   Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
    Recruiting
  • Stress Echo 2020 - The International Stress Echo Study
    NCT03049995
    Conditions:   Coronary Artery Disease;   Heart Failure;   Hypertrophic Cardiomyopathy;   Aortic Valve Disease;   Athletes Heart;   Tetralogy of Fallot;   Pulmonary Arterial Hypertension
    Interventions:   Procedure: Left ventricular contractile reserve SE;   Procedure: B-lines SE;   Procedure: Left ventricular outflow tract gradient SE;   Procedure: Diastolic function SE;   Procedure: Mitral regurgitation SE;   Procedure: Pulmonary hemodynamics SE;   Procedure: Coronary flow reserve SE
    Sponsors:   Fatebenefratelli Hospital;   Institute of Clinical Physiology, CNR, Pisa,Italy;   Salerno Hospital, Italy;   Monaldi Hospital, Napoli, Italy;   University of Pisa, Italy;   San Luca Hospital, Lucca, Italy;   Careggi University Hospital, Florence, Italy;   Federico II University;   San Carlo Public Hospital, Potenza, Italy;   Royal Brompton & Harefield NHS Foundation Trust;   Ospedale dell'Angelo;   University of Parma;   Hospital Clinics, Trieste, Italy;   Federal University of Rio Grande do Sul;   Hospital San José, Criciuma, Brasil;   Hospital San Vicente de Paulo, Passo Fundo, Brasil;   University of Belgrade,Serbia;   University of Szeged, Hungary;   Elisabeth Hospital, Hodmezovasarhely, Hungary;   Sandro Pertini Hospital, Rome, Italy;   Hospital Clinics, Bari, Italy;   Ospedale Nottola, Siena, Italy;   University of Catania, Italy;   Medika Cardiocenter, Saint Petersburg, Russian Federation;   Acibadem City Clinic Tokuda Hospital;   Investigaciones Medicas, Buenos Aires, Argentina;   Tomsk National Research Scientific Centre of Russian Academy of Sciences, Tomsk, Russian Federation
    Recruiting
  • Prognosis of Subjects With Unexplainable Precordial Deep T-wave Inversion Without Wall Thickness> 15mm
    NCT02692508
    Conditions:   Cardiomyopathy;   Hypertrophic
    Intervention:  
    Sponsors:   Chinese Academy of Medical Sciences, Fuwai Hospital;   Beijing Chao Yang Hospital;   Beijing Anzhen Hospital;   Peking Union Medical College Hospital;   Xuanwu Hospital, Beijing
    Recruiting
  • Mobilization of Endothelial Progenitor Cells and Aspirin
    NCT02674958
    Condition:   Hypertrophic Obstructive Cardiomyopathy
    Intervention:   Drug: Aspirin
    Sponsor:   Ottawa Heart Institute Research Corporation
    Recruiting
  • China Structural Ventricular Arrhythmias Registry
    NCT03821051
    Condition:   Ventricular Arrythmia
    Intervention:  
    Sponsors:   China National Center for Cardiovascular Diseases;   Renmin Hospital of Wuhan University;   The First Affiliated Hospital with Nanjing Medical University;   Second Affiliated Hospital of Nanchang University;   Sir Run Run Shaw Hospital;   West China Hospital;   Beijing Anzhen Hospital;   General Hospital of Shenyang Military Region;   Xuzhou Central Hospital;   First Affiliated Hospital, Sun Yat-Sen University
    Recruiting
  • The PARTNER 3 - AVIV Trial
    NCT03003299
    Conditions:   Aortic Stenosis;   Cardiomyopathy, Hypertrophic
    Intervention:   Device: Edwards SAPIEN 3 transcatheter valve, Model 9600TFX
    Sponsor:   Edwards Lifesciences
    Recruiting
  • Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology
    NCT03842163
    Condition:   Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
    Intervention:   Diagnostic Test: Diagnosis of TTR amyloidosis cardiomyopathy
    Sponsor:   Pfizer
    Recruiting
  • Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
    NCT03479580
    Conditions:   Hypertrophic;   Ischemic;   Restrictive Cardiomyopathy;   Dilated Cardiomyopathies
    Intervention:   Other: Patients with a cardiomyopathy
    Sponsors:   University Hospital, Grenoble;   Clinique Belledonne;   Groupe Hospitalier Mutualiste de Grenoble;   Centre Hospitalier Annecy Genevois;   Centre Hospitalier Metropole Savoie
    Recruiting

Popular Now

  • Privacy Policy
  • Ad and Cookie Policy
  • Infringement Policy
  • Terms of Use
  • Email Policy
  • Contact Us
  • Post Clinical Trials
  • Join Clinical Trials
  • Volunteer Login
  • Recruiters Login
  • Frequently Asked Questions
  • Blog
  • Find Clinical Trials
  • Find Volunteers
  • Trials by Category
  • Trials by Location
  • Volunteers by Category
  • Volunteers by Location
All clinical trials are registered and certified with clinicaltrials.gov. Data via U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. JoinClinicaltrials.com (Aunica Media llc) is a free resource that provides individuals and companies with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct clinical trials nor endorses them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free
©2001-2019 Aunica Media LLC